Other Information
−Removed: Not applicable.
+Added: On June 7, 2024 , Daniel T.
+Added: Scavilla , President and Chief Executive Officer , adopted a Rule 10b5-1 Trading Plan.
+Added: Scavilla’s Rule 10b5-1 Trading Plan, which has a term ending upon the earlier of August 31, 2025 or the sale of all shares subject to the plan, provides for the sale of up to 190,000 shares of Class A common stock pursuant to the terms of the plan.
+Added: On June 13, 2024 , Kelly G.
+Added: Huller , Senior Vice President and General Counsel , adopted a Rule 10b5-1 Trading Plan.
+Added: Huller’s Rule 10b5-1 Trading Plan, which has a term ending upon the earlier of January 31, 2026 or the sale of all shares subject to the plan, provides for the sale of up to 15,000 shares of Class A common stock pursuant to the terms of the plan.
The following is a list of exhibits filed as part of this Quarterly Report on Form 10-Q.
1 unchanged sentence
For exhibits incorporated by reference, the location of the exhibit in the previous filing is indicated in parentheses.
+Added: 2021 Equity Incentive Plan, as amended (incorporated by reference to Exhibit 10.1 to our Form 8-K filed on June 6, 2024).
Certification by Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
15 unchanged sentences
GLOBUS MEDICAL, INC.
+Added: August 6, 2024
/s/ DANIEL T.
1 unchanged sentence
(Principal Executive Officer)
+Added: August 6, 2024
/s/ KEITH PFEIL
Chief Financial Officer and Chief Operating Officer
+Added: Chief Accounting Officer
Executive Vice President
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.